David Miklos, MD

Articles by David Miklos, MD

CAR T-Cell Therapy Appears Promising in Relapsed/Refractory DLBCL

April 15th 2020

David Miklos, MD, discusses exciting data for the use of chimeric antigen receptor T-cell therapy as treatment of patients with diffuse large B-cell lymphoma.

Highlighting CAR T Cell Options for Relapsed/Refractory DLBCL

ByDavid Miklos, MD

March 14th 2019

David Miklos, MD, discusses his advice for community oncologists treating patients with diffuse large B-cell lymphoma.

Latest Updated Articles

$CAR T-Cell Therapy Appears Promising in Relapsed/Refractory DLBCL$
CAR T-Cell Therapy Appears Promising in Relapsed/Refractory DLBCL
Published: April 15th 2020 | Updated:
$Highlighting CAR T Cell Options for Relapsed/Refractory DLBCL$
Highlighting CAR T Cell Options for Relapsed/Refractory DLBCL
Published: March 14th 2019 | Updated: